Skip to main content
Home > Field of Cooperation > Health Research > Targeting MYCN/NCYM for cancer therapy
Targeting MYCN/NCYM for cancer therapy
Principal Investigator / Affiliation Yoshitaka Hippo (Department Head) / Chiba Cancer Center flag Japan Japan
Tao Liu (Group Leader) / The University of New South Wales flag Australia Australia
Edy Meiyanto (Professor) / Gadjah Mada University flag Indonesia Indonesia
Year Adopted 2021
Research Period 3 years
General Description of the Research Project The aim of this project is to develop novel therapeutic strategies for liver cancer by targeting MYCN/NCYM. The effects of anti-cancer agents inhibiting MYCN/NCYM function, obtained either from natural resources or through chemical synthesis, will be examined using patient-derived organoid and mouse models for potential translation into clinical trials. Multi-omics will reveal the molecular mechanisms underlying the tumor suppressive effects
Photo Gallery  


Principal Investigator / Country of Research Team
Photo Yoshitaka Hippo

Yoshitaka Hippo

flag Japan
Photo Tao Liu

Tao Liu

flag Australia
Photo Edy Meiyanto

Edy Meiyanto

flag Indonesia